ArticlePloS one2025
Variant evolution graph: Can we infer how SARS-CoV-2 variants are evolving?
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Graph-based representations in modern protein science.The Biochemical journal · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The SARS-CoV-2 virus has undergone extensive mutations over time, resulting in considerable genetic diversity among circulating strains. This diversity directly affects important viral characteristics, such as transmissibility and disease severity. During a viral outbreak, the rapid mutation rate produces a large cloud of variants, referred to as a viral quasispecies. However, many variants are lost due to the bottleneck of transmission and survival. Advances in next-generation sequencing have enabled continuous and cost-effective monitoring of viral genomes, but constructing reliable phylogenetic trees from the vast collection of sequences in GISAID (the Global Initiative on Sharing All Influenza Data) presents significant challenges. We introduce a novel graph-based framework inspired by quasispecies theory, the Variant Evolution Graph (VEG), to model viral evolution. Unlike traditional phylogenetic trees, VEG accommodates multiple ancestors for each variant and maps all possible evolutionary pathways. The strongly connected subgraphs in the VEG reveal critical evolutionary patterns, including recombination events, mutation hotspots, and intra-host viral evolution, providing deeper insights into viral adaptation and spread. We also derive the Disease Transmission Network (DTN) from the VEG, which supports the inference of transmission pathways and super-spreaders among hosts. We have applied our method to genomic data sets from five arbitrarily selected countries - Somalia, Bhutan, Hungary, Iran, and Nepal. Our study compares three methods for computing mutational distances to build the VEG, sourmash, pyani, and edit distance, with the phylogenetic approach using Maximum Likelihood (ML). Among these, ML is the most computationally intensive, requiring multiple sequence alignment and probabilistic inference, making it the slowest. In contrast, sourmash is the fastest, followed by the edit distance approach, while pyani takes more time due to its BLAST-based computations. This comparison highlights the computational efficiency of VEG, making it a scalable alternative for analyzing large viral data sets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.